TIME IS LIFE
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 May 2011)
What this means for you
This application is over — abandoned 02 May 2011. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77190373
- Mark type
- Stylized text
- Filed
- 25 May 2007
- Published for opposition
- 03 Aug 2010
- Abandoned
- 02 May 2011
- Attorney of record
- Gary D. Krugman
Goods and services
- Class 001 — Chemicals: Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents
- Class 010 — Medical apparatus: Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis and hemofiltration
- Class 035 — Advertising and business services: Computerized database management, namely, processing data for third parties in the field of drug development
- Class 041 — Education and entertainment services: Educational services, namely, providing seminars and workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, and gendiagnostics
- Class 042 — Scientific and technological services: Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; services of a biotechnological laboratory, namely, conducting laboratory research for others in the field of drug research and development; pharmaceutical research consulting, namely, performing pre-clinical studies; performing quality control for others; preparation of expert opinions in the field of chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry; product research and development of medical devices and pharmaceutical preparations, and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic research services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; performance of pre-clinical research namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; biochemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment; scientific research on and development of medical diagnostic equipment and pharmaceutical preparations and products for the treatment of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment
Owner
- Paion Deutschland GmbH, Aachen, DE
- Paion Deutschland GmbH, Aachen, DE
Prosecution history
- 02 May 2011 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 02 May 2011 — ABANDONMENT - NO USE STATEMENT FILED
- 28 Sept 2010 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Aug 2010 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Aug 2010 — PUBLISHED FOR OPPOSITION
- 29 Jun 2010 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 28 Jun 2010 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jun 2010 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Jun 2010 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Jun 2010 — ASSIGNED TO LIE
- 08 Jun 2010 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Dec 2009 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Dec 2009 — NON-FINAL ACTION E-MAILED
- 09 Dec 2009 — NON-FINAL ACTION WRITTEN
- 19 Nov 2009 — TEAS/EMAIL CORRESPONDENCE ENTERED